Abstract
Constipation has been defined objectively in various ways, but its importance lies in the distress it causes as a symptom. The components of this symptom are primarily difficult and infrequent defecation, but may also include such sensations as flatulence, bloating, rectal dissatisfaction, and malaise.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cartwright A, Hockey L, Anderson JL. 1973. Life Before Death. London: Routledge and Kegan Paul, 23.
Holmes S. 1989. Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–79.
Sykes NP. 1990. Methods of assessment of bowel function in patients with advanced cancer. Palliat Med 4:287–292.
Bassotti G, Gaburri M. 1988. Manometric investigation of high amplitude propagated contractile activity of the human colon. Am J Physiol 255:G660–G664.
Holdstock DJ, Misiewicz JJ, Smith T, Rowlands EH. 1970. Propulsion (mass movements) in human colon and its relation to meals and somatic activity. Gut 2:91–99.
Wigzell FW. 1969. The health of nonagenarians. Gerontol Clin 11:137–144.
Adler HF, Atkinson AJ, Ivy AC. 1942. Effect of morphine and dilaudid on the ileum and of morphine, dilaudid and atropine on the colon of man. Arch Intern Med 69:974–985.
Margolin S. 1954. Decreased gastrointestinal propulsive activity after instracranial morphine. Fed Proc 13:383–384.
Manara L, Bianchi G, Ferretti P, Tavani A. 1986. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther 237:945–948.
Manara L, Bianchi G, Ferretti P, Monferini E, Strada D, Tavani A. 1980. Local and CNS-mediated effects of morphine and narcotic antagonists on gastrointestinal propulsion in rats. In Way EL (ed), Endogenous and Exogenous Opiate Agonists and Antagonists. New York: Pergamon, 143–146.
Ruppin H. 1987. Review: loperamide — a potent antidiarrhoeal drug with actions along the alimentary tract. Aliment Pharmacol Ther 1:179–190.
Kreek MJ, Schaefer RA, Hahn EF, Fishman J. 1983. Naloxone, a specific opioid antagonist reverses chronic idiopathic constipation. Lancet i:261–262.
Kreek MJ, Paris P, Bartol MA, Mueller D. 1984. Effects of short term oral administration of the specific opioid antagonist naloxone on faecal evacuation in geriatric patients. Gastroenterology 86:1144.
Connell AM, Hilton C, Irvine G, Lennard-Jones JE, Misiewicz JJ. 1965. Variation in bowel habit in two population samples. Br Med J ii: 1095–1099.
Wyman JB, Mann JB, Heaton KW, Manning AP, Wicks ACB. 1978. Variability of colonic function in healthy subjects. Gut 19:146–150.
Bruera E, Brenneis C, Michaud M, MacDonald N. 1987. Continous s.c. infusion of metoclopromide for treatment of narcotic bowel syndrome. Cancer Treat Rep 71:1121–1122.
Donaldson AN. 1922. Experimental study of intestinal stasis. JAMA 78:884–888.
Mumford SP. 1986. Can high fibre diets improve the bowel function in patients on radiotherapy ward? Cited in Twycross RG, Lack SA, Control of Alimentary Symptoms in Far Advanced Cancer. London: Churchill Livingstone, 166–207.
Twycross RG, Lack SA. 1986. Control of Alimentary Symptoms in Far Advanced Cancer. London: Churchill Livingstone.
Sykes NP. 1996. A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 11:363–369.
Sykes NP. 1991 Clinical comparison of laxatives in a hospice. Palliat Med 5:307–314.
Maguire LC, Yon JL, Miller E. 1981 Prevention of narcotic-induced constipation. N Eng J Med 305:1651
Debognie JC, Phillips SF. 1978. Capacity of the human colon to absorb fluid. Gastroenterology 74:698–703.
Condon JR, South M, Wolveson RL, Brinkley D. 1978. Radiation diarrhoea and cholestryramine. Postgrad Med J 54:838–839.
Mennie AT, Dalley VM, Dinneen LC, Collier HO. 1975. Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet ii:942–943.
Edes TD, Walk BE, Austin JL. 1990. Diarrhoea in tube-fed patients: feeding formula not necessarily the cause. Am J Med 88:91–93.
Mercadante S. 1992. Treatment of diarrhoea due to enterocolic fistula in a terminal cancer patient. Palliat Med 6:257–259.
Boyd K. 1993. Diabetes mellitus in hospice patients: some guidelines. Palliat Med 7:163–164.
Bruera E, Catz Z, Hooper R, Leattle B, MacDonald N. 1987. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 2:19–21
Fainsinger RL, MacEachern T, Miller MJ, Bruera E, Spachynski K, Kuehn N, Hanson J. 1994. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 9:298–302.
Mercadante S. 1995. Diarrhoea in terminally ill patients, pathophysiology and treatment. J Pain Symptom Manage 10:298–309.
Norton JA, Doppman JL, Jensen RT. 1989. Cancer of the endocrine system. In De Vita VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology, 3rd ed. Philadelphia: Lippincott, 1269-344.
DuPont HL, Ericsson CD, DuPont MW, Luna AC, Mathewson JJ. 1990. A randomized, open-label comparison of non-prescription loperamide and attapulgite in the symptomatic treatment of acute diarrhoea. Am J Med 88(Suppl 6A):205–235.
De Conno F, Caraceni A, Zecca E, Spoldi E, Ventafridda V. 1991 Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 6:484–486.
Fedorak RN, Field M, Chang EB. 1985. Treatment of diabetic diarrhoea with Clonidine. Annals of Internal Medicine 102:197–199.
Hanks G, Portenoy RK, MacDonald N, Forbes K. 1998. Difficult pain problems. In Doyle D, Hanks G, MacDonald N (eds), Oxford Textbook of Palliative Medicine (2nd edition). Oxford: University Press, 464.
World Health Organisation Cancer Pain Relief. (2nd edition). Geneva: WHO, 1996.
Zenz M, Strumpf M, Tryba M. 1992. Long-term opioid therapy in patients with chronic non-malignant pain. Journal of Pain and Symptom Management 7:69–77.
Boquet J, Moore N, Lhuintre JP, Boismare F. 1986. Diltiazem for proctalgia fugax. Lancet 1:1493.
Bristow A, Foster JMG. 1988. Lumbar sympathectomy in the management of rectal tenesmoid pain. Annals of the Royal College of Surgeons of England 70:38–39.
Cutrin Prieto C, Casal Iglesias L, Batalla Eiras A, et al. 1991 Treatment with indomethacin for the control of metabolic disorder caused by a villous adenoma of the rectum. Annales de Medicina Interna 8:345–346.
Brunetaud JM, Maunoury V, Cochelard D, Adenis A, Boniface B, Cortot A, Paris JC. 1989. Lasers in rectosigmoid cancers: factors affecting immediate and long term results. Bailliere’s Clinical Gastroenterology 3:615–626.
Abel ME, Chiu YS, Russell TR, Volpe PA. 1993. Autologous fibrin glue in the treatment of rectovaginal and complex fistulas. Diseases of the Colon and Rectum 36:447–449.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sykes, N. (1999). Palliation of abdominal symptoms. In: von Gunten, C.F. (eds) Palliative Care and Rehabilitation of Cancer Patients. Cancer Treatment and Research, vol 100. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5003-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5003-7_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7272-1
Online ISBN: 978-1-4615-5003-7
eBook Packages: Springer Book Archive